Please Wait...


Translation skills

Main profile

Klaus Engelke
Klaus Engelke, PhD.
Director of Special Imaging Techniques

Professor Klaus Engelke received a Ph.D. in Physics from the University of Hamburg, Germany for his pioneering work on µCT using Synchrotron Radiation. Afterwards he joined the Osteoporosis Research Group at UCSF (University of California at San Francisco) to develop advanced radiographic methods for the diagnosis of osteoporosis. At UCSF he also developed the first workstation for vertebral fracture analysis using digitized x-rays. He then joined the newly formed Institute of Medical Physics (IMP) at the University of Erlangen, Germany to develop desktop µCT Scanners and advanced image processing methods. Prof. Engelke joined Synarc, now Bioclinica, as a Director of Special Imaging Techniques in 2005. At the University of Erlangen he continues to develop novel in vivo and in vitro image acquisition and analysis techniques for the musculoskeletal field. He has authored more than 250 peer reviewed publications and more than 350 conference contributions.

In 2007, 2013 and 2015 Prof. Engelke chaired or was member of the QCT Task Forces that developed the official positions of the International Society of Clinical Densitometry (ISCD). He is member of the committee for the development of the German guidelines for the diagnosis and treatment of osteoporosis under the auspices of the DVO ‘Dachverband Osteologie’. He is also a member of the scientific advisory committee of the International Osteoporosis Foundation (IOF) and co-chaired the Committee on Bone Densitometry of the International Commission on Radiation Units (ICRU). He was co-president of the German 2011 Osteology meeting and co-president of the 21st International Bone Densitometry Workshop and 7th European Symposium on Ultrasonic Characterization of Bone in 2017 in Banz, Germany

In 2017 he was awarded the Dr. John P. Bilezikian Global Leadership Award from the International Society for Clinical Densitometry, which recognizes Klaus for his contributions to the advancement of osteoporosis and bone imaging research. In 2019 he was awarded the ‘Excellence in Research Award’ from the European Calcified Tissue Society (ECTS) for his pioneering research in musculoskeletal imaging.

Authored Publications

Marietta Herrmann, Klaus Engelke, Regina Ebert, Sigrid Müller-Deubert, Maximilian Rudert, Fani Ziouti, Franziska Jundt, Dieter Felsenberg and Franz Jakob Interactions between Muscle and Bone—Where Physics Meets Biology in Biomolecules March 2020 


Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica’s Resale #IRT offers flexible configuration, delivery in weeks not months, & an affordable, predictable…
Bioclinica (3 days ago)
The Clinical Trial Management System (CTMS) Starter Package from Bioclinica saves time and minimizes the risk often…
Bioclinica (5 days ago)
We are pleased to announce @directbiologics will leverage Bioclinica's IRT solution for its EXIT #COVID19 study. Th…
Bioclinica (2 weeks ago)
The integration of Bioclinica CTMS & eTMF with SharePoint enable teams to work in familiar programs & remote work a…
Bioclinica (2 weeks ago)
Ready for a centralized view into your studies but don’t want to take on the risk of procuring a CTMS? With our rap…
Bioclinica (3 weeks ago)
Minimize the risk of not having enough medication at a site to assign to a subject with our end-to-end #RTSM soluti…
Bioclinica (3 weeks ago)